SPBC1773.06c Antibody

What is SPBC1773.06c and why is it studied in research?

SPBC1773.06c is a protein found in Schizosaccharomyces pombe (fission yeast), specifically in strain 972 / ATCC 24843. The protein is cataloged in UniProt under the identifier O94564 . Researchers study this protein primarily in the context of fission yeast biology, which serves as an important model organism for understanding eukaryotic cellular processes. S. pombe is particularly valuable for studying cell cycle regulation, chromosome dynamics, and stress responses due to its relatively simple genome and genetic tractability. Antibodies against SPBC1773.06c enable visualization and quantification of this protein in various experimental contexts, allowing researchers to investigate its expression patterns, localization, and potential functions within the cell.

What experimental applications is the SPBC1773.06c antibody suitable for?

The SPBC1773.06c antibody (product code CSB-PA530928XA01SXV) has been specifically tested and validated for Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blotting (WB) applications . For Western blotting, the antibody enables identification of the antigen in complex protein mixtures, providing information about protein expression levels and molecular weight. In ELISA applications, the antibody allows for quantitative detection of SPBC1773.06c in various sample types. While not explicitly validated for other techniques, researchers might consider optimizing the antibody for immunoprecipitation, immunocytochemistry, or chromatin immunoprecipitation based on experimental needs and following standard antibody validation protocols for these applications.

What are the proper storage and handling conditions for SPBC1773.06c antibody?

The SPBC1773.06c antibody should be stored at either -20°C or -80°C upon receipt . Repeated freeze-thaw cycles should be avoided as they can compromise antibody integrity and performance. The antibody is supplied in liquid form with a storage buffer containing 50% Glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative . The glycerol helps prevent freeze damage while the Proclin 300 prevents microbial growth. For routine use, researchers should aliquot the antibody into smaller volumes upon initial thawing to minimize freeze-thaw cycles. Working dilutions should be prepared fresh before use and can typically be stored at 4°C for short periods (1-2 weeks), though specific stability should be determined experimentally for each application.

How should researchers validate the specificity of SPBC1773.06c antibody?

Antibody validation is crucial for ensuring experimental reliability. For SPBC1773.06c antibody, researchers should implement multiple validation approaches. First, positive and negative controls should be established - wild-type S. pombe expressing SPBC1773.06c versus deletion mutants lacking the gene. Western blotting should show the expected molecular weight band in wild-type samples and absence in deletion strains. Peptide competition assays can be performed where pre-incubation of the antibody with purified SPBC1773.06c protein or peptide should abolish signal detection. Researchers might also consider using tagged versions of SPBC1773.06c and comparing detection patterns between the antibody against the native protein and antibodies against the tag. Cross-reactivity with other S. pombe proteins should be assessed, particularly those with sequence homology to SPBC1773.06c. Finally, correlation of protein detection with mRNA levels via RT-PCR or RNA-seq can provide additional validation of antibody specificity.

What sample preparation methods are recommended for SPBC1773.06c detection in fission yeast?

For optimal detection of SPBC1773.06c in S. pombe, careful sample preparation is essential. Cells should be harvested in mid-log phase to ensure consistent protein expression. For Western blotting, a robust cell lysis protocol is recommended: mechanical disruption using glass beads in a lysis buffer containing protease inhibitors (such as PMSF, leupeptin, and pepstatin A) to prevent protein degradation. The buffer should contain detergents appropriate for membrane protein extraction if SPBC1773.06c is associated with membranes. For ELISA applications, optimization of antigen coating concentrations is crucial. Sample preparation should also consider the native state of SPBC1773.06c - if the protein forms complexes or undergoes post-translational modifications, sample preparation should preserve these characteristics when relevant to the research question. Standardizing cell numbers or total protein concentration across samples is essential for quantitative comparisons.

How can computational approaches like RosettaAntibodyDesign (RAbD) be applied to enhance SPBC1773.06c antibody specificity?

RosettaAntibodyDesign (RAbD) represents a cutting-edge computational framework that could significantly improve SPBC1773.06c antibody design. RAbD samples the diverse sequence, structure, and binding space of antibodies to optimize interaction with target antigens . For enhancing SPBC1773.06c antibody specificity, researchers could use RAbD to redesign complementarity-determining regions (CDRs) that interact with unique epitopes of SPBC1773.06c. The process would begin with the three-dimensional structure of the SPBC1773.06c protein, which would serve as input for RAbD to sample different CDR structures from its database annotated with CDR cluster nomenclature . The algorithm utilizes sequence profiles for CDR clusters to sample amino acid changes during antibody design and exploits existing structure optimization strategies in Rosetta . By focusing on epitopes unique to SPBC1773.06c and absent in related proteins, researchers could computationally design antibodies with enhanced specificity. The computational designs would then require experimental validation, but this approach could significantly reduce the time and resources needed to develop highly specific antibodies compared to traditional methods.

What considerations are important for optimizing Western blot protocols with SPBC1773.06c antibody?

Optimizing Western blot protocols for SPBC1773.06c detection requires systematic attention to multiple parameters. First, researchers should determine the optimal antibody concentration through titration experiments, typically starting with the manufacturer's recommended dilution (1:500 to 1:2000) and adjusting as needed. Transfer efficiency can be critical for SPBC1773.06c detection - proteins of different molecular weights require different transfer conditions, so optimization based on the expected size of SPBC1773.06c is essential. Blocking conditions significantly impact specificity; researchers should compare different blocking agents (BSA, non-fat milk, commercial blockers) to identify which provides the best signal-to-noise ratio. Incubation times and temperatures for both primary (SPBC1773.06c antibody) and secondary antibodies should be systematically tested. The choice of detection method (chemiluminescence, fluorescence, colorimetric) can dramatically affect sensitivity and dynamic range. Finally, researchers should establish a quantification standard curve using recombinant SPBC1773.06c protein at known concentrations to enable accurate quantification. A detailed troubleshooting protocol should be established to address common issues such as high background, absence of signal, or unexpected bands.

What strategies can researchers employ to map the epitope recognized by SPBC1773.06c antibody?

Epitope mapping for SPBC1773.06c antibody provides critical information about antibody specificity and can guide experimental applications. Several complementary approaches are recommended. Peptide arrays can be employed where overlapping synthetic peptides spanning the SPBC1773.06c sequence are tested for antibody binding, identifying linear epitopes. For conformational epitopes, hydrogen-deuterium exchange mass spectrometry (HDX-MS) can identify regions of the protein protected from deuterium exchange when bound to the antibody. X-ray crystallography or cryo-electron microscopy of the antibody-antigen complex provides the most detailed structural information but requires significant expertise. Mutagenesis studies, where specific amino acids in SPBC1773.06c are systematically mutated and tested for altered antibody binding, can pinpoint critical residues in the epitope. Computational approaches like molecular docking can predict antibody-antigen interactions when structural information is available for both molecules. Finally, cross-reactivity testing against related proteins with known sequence homology to SPBC1773.06c can help define the uniqueness of the recognized epitope and inform experimental design.

What considerations are important when designing co-immunoprecipitation experiments using SPBC1773.06c antibody?

Co-immunoprecipitation (Co-IP) with SPBC1773.06c antibody requires careful experimental design to identify physiologically relevant protein interactions. The choice of lysis conditions is critical - buffers should be mild enough to preserve protein-protein interactions while sufficient to extract SPBC1773.06c from its cellular compartment. Detergent selection is particularly important; non-ionic detergents like NP-40 or Triton X-100 at 0.5-1% are typically suitable starting points. Antibody orientation must be considered - whether to conjugate the SPBC1773.06c antibody to beads or use it free in solution followed by Protein A/G capture. Pre-clearing lysates with beads alone reduces non-specific binding. Elution conditions should be optimized to efficiently release SPBC1773.06c and its binding partners without contamination by the antibody itself. Controls must include a non-specific antibody of the same isotype and, ideally, immunoprecipitation from cells lacking SPBC1773.06c. Crosslinking approaches may be necessary for transient interactions. For validation, reciprocal Co-IPs (using antibodies against suspected interaction partners) and mass spectrometry analysis of co-precipitated proteins provide complementary evidence for specific interactions.

What quantification methods are most appropriate for SPBC1773.06c analysis?

Quantification of SPBC1773.06c requires selection of methods appropriate to experimental goals and available resources. For relative quantification across samples, densitometry analysis of Western blots is straightforward but has a limited dynamic range of approximately 10-fold. Normalization to housekeeping proteins like actin or GAPDH is essential, though researchers should verify that treatment conditions don't alter these reference proteins. For absolute quantification, ELISA using a standard curve of recombinant SPBC1773.06c protein provides greater accuracy and a wider dynamic range than Western blotting. Mass spectrometry-based approaches, particularly selected reaction monitoring (SRM) or parallel reaction monitoring (PRM), offer high specificity and sensitivity for quantification, though they require specialized equipment and expertise. Digital technologies like Single Molecule Counting (SMC) or digital ELISA platforms provide even greater sensitivity for low-abundance proteins. Flow cytometry can quantify SPBC1773.06c in individual cells if suitable protocols for intracellular staining in yeast are established. Researchers should select quantification methods based on the expected expression level of SPBC1773.06c, required sensitivity, and available instrumentation.

How can researchers troubleshoot inconsistent results with SPBC1773.06c antibody?

Troubleshooting inconsistent results with SPBC1773.06c antibody requires systematic evaluation of multiple experimental variables. A structured approach should begin with antibody quality assessment - checking for signs of degradation through test blots or ELISAs and comparing different antibody lots. Sample preparation variables should be standardized, including cell growth conditions, lysis methods, and protein quantification. A common source of inconsistency is variability in blocking conditions or wash stringency; standardizing these steps with timed intervals and consistent buffer preparation is essential. Temperature fluctuations during incubation steps can significantly impact results and should be carefully controlled. For Western blots, transfer efficiency should be verified using stained molecular weight markers or reversible total protein stains. Researchers should maintain detailed laboratory notebooks documenting all experimental conditions, including reagent lots, incubation times, and equipment settings. When inconsistencies persist, parallel processing of all samples with an antibody against a housekeeping protein can help identify whether the issue is specific to SPBC1773.06c detection or reflects broader technical problems.

What approaches can researchers use to increase sensitivity for detecting low abundance SPBC1773.06c?

Detecting low-abundance SPBC1773.06c requires specialized approaches to enhance sensitivity. Sample enrichment techniques such as immunoprecipitation prior to Western blotting can concentrate the target protein. For Western blotting, using high-sensitivity chemiluminescent substrates with longer exposure times can improve detection of faint signals, though care must be taken to avoid overexposure of stronger bands. PVDF membranes typically provide better protein retention than nitrocellulose, potentially enhancing signal. Enhanced chemiluminescence (ECL) plus systems or fluorescent secondary antibodies with appropriate imaging systems can offer 10-100 fold increases in sensitivity over standard ECL. For particularly challenging samples, tyramide signal amplification (TSA) can dramatically boost sensitivity through enzymatic deposition of multiple reporter molecules. In ELISA applications, employing the biotin-streptavidin system provides significant signal amplification. Single-molecule detection technologies like SMC or digital ELISA platforms can detect proteins at femtomolar concentrations. Additionally, researchers might consider using more sensitive mass spectrometry approaches with targeted methods like parallel reaction monitoring (PRM) to detect and quantify low-abundance SPBC1773.06c.

How should researchers interpret Western blot band patterns when using SPBC1773.06c antibody?

Interpreting Western blot band patterns from SPBC1773.06c antibody requires careful analysis beyond simply identifying the expected molecular weight band. The expected molecular weight should be calculated from the amino acid sequence, accounting for potential post-translational modifications. Multiple bands could indicate several distinct possibilities that require different interpretations: alternative splice variants of SPBC1773.06c, post-translational modifications (phosphorylation, glycosylation, ubiquitination), proteolytic degradation products, or non-specific binding. To distinguish between these possibilities, researchers should analyze molecular weight patterns systematically. Post-translational modifications typically appear as higher molecular weight bands at consistent intervals above the main band. Degradation products appear as multiple lower molecular weight bands, often with inconsistent patterns between samples. Controls with phosphatase treatment can confirm phosphorylation, while deglycosylation enzymes can identify glycosylated forms. Confirming specificity through knockout/knockdown samples is essential for proper interpretation. Cell-type or condition-specific differences in band patterns may indicate biologically significant regulation of SPBC1773.06c processing or modification that merits further investigation.

What experimental design principles are recommended for studying SPBC1773.06c dynamics during the cell cycle?

Studying SPBC1773.06c dynamics throughout the cell cycle requires careful experimental design to capture temporal changes accurately. Synchronization of S. pombe cells is essential and can be achieved through multiple methods: elutriation centrifugation to separate cells by size/density, nitrogen starvation and release, temperature-sensitive cell cycle mutants, or chemical synchronization. Each method has advantages and potential artifacts that should be considered. Sample collection intervals should be determined based on the length of the S. pombe cell cycle (~2-3 hours) with frequent sampling (every 10-15 minutes) during transitions of interest. Flow cytometry with DNA content analysis should confirm successful synchronization in parallel samples. For protein analysis, quantitative Western blotting with normalization to a cell-cycle-independent loading control is suitable for population-level studies. Immunofluorescence microscopy enables visualization of SPBC1773.06c localization changes during cell cycle progression. For higher temporal resolution, time-lapse fluorescence microscopy using GFP-tagged SPBC1773.06c can track dynamics in living cells. Complementary approaches should examine mRNA levels via RT-qPCR to distinguish transcriptional from post-transcriptional regulation. Including known cell cycle markers (e.g., Cdc13, Cdc2) as positive controls helps validate the experimental system.

What are the advantages and limitations of polyclonal versus monoclonal antibodies for SPBC1773.06c detection?

For researchers conducting critical experiments, developing complementary assays using both antibody types would provide the most robust validation of results.

How does the use of computational tools like RAbD compare to traditional antibody development for proteins like SPBC1773.06c?

Computational antibody design tools like RosettaAntibodyDesign (RAbD) represent an emerging approach that could complement traditional antibody development methods for targets like SPBC1773.06c. RAbD samples diverse sequence, structure, and binding space to optimize antibody-antigen interactions through structural bioinformatics . This computational methodology could potentially overcome limitations encountered with traditional antibody development, particularly for challenging epitopes.

Traditional development of antibodies against SPBC1773.06c typically involves immunizing rabbits with recombinant protein or peptide antigens, followed by polyclonal antibody purification . While established and reliable, this process can be time-consuming (3-4 months) and may yield antibodies with suboptimal specificity or affinity.

The RAbD framework offers several advantages: it can sample antibody sequences and structures by grafting from canonical clusters of CDRs, perform sequence design according to amino acid profiles of each cluster, and optimize antibody-antigen binding through flexible-backbone design protocols . For SPBC1773.06c, this could enable design of antibodies specifically targeting unique epitopes that distinguish it from related proteins.

Experimental testing of computationally designed antibodies suggests promising results. In one study, AbDesign (a similar computational approach) created antibodies against insulin and mycobacterial acyl-carrier protein that, after refinement, achieved affinity in the 50-100nM range . Additionally, mutation studies confirmed the importance of computationally identified epitope residues in binding .

The ideal approach for developing optimal SPBC1773.06c antibodies likely combines these methods - using computational design to identify promising candidates, followed by traditional testing and refinement.

What methods can researchers employ to study the functional impact of SPBC1773.06c post-translational modifications?

Understanding post-translational modifications (PTMs) of SPBC1773.06c requires integrated experimental approaches that go beyond simple detection. While the specific PTMs of SPBC1773.06c have not been characterized in detail, researchers can apply general methodologies tailored to this protein.

First, identification of PTM sites requires mass spectrometry analysis of purified SPBC1773.06c, preferably using enrichment techniques specific to the PTM type (e.g., phosphopeptide enrichment, glycopeptide enrichment). Comparative analysis of SPBC1773.06c obtained from cells in different physiological states can reveal condition-specific PTMs. Western blotting with modification-specific antibodies (anti-phospho, anti-ubiquitin) can complement mass spectrometry data.

For functional characterization, researchers should consider site-directed mutagenesis approaches where identified PTM sites are mutated to either prevent modification (e.g., Ser/Thr to Ala for phosphorylation) or mimic constitutive modification (e.g., Ser/Thr to Asp/Glu for phosphorylation). These mutants can be expressed in SPBC1773.06c deletion backgrounds to assess phenotypic consequences.

Temporal dynamics of SPBC1773.06c PTMs can be monitored through pulse-chase experiments combined with immunoprecipitation and mass spectrometry. This approach reveals modification kinetics and potential hierarchical relationships between different PTMs on the same protein.

For studying physiological significance, researchers should identify the enzymes responsible for adding/removing the modifications through candidate testing or proteome-wide screens. Finally, proximity labeling methods like BioID or APEX can identify proteins that interact specifically with modified versus unmodified SPBC1773.06c, revealing PTM-dependent protein interactions.

How can single-cell technologies be adapted for studying SPBC1773.06c in heterogeneous yeast populations?

Single-cell technologies offer powerful approaches for understanding SPBC1773.06c expression and function in heterogeneous S. pombe populations. These methods are particularly valuable for studying SPBC1773.06c in contexts where population averaging might mask important cell-to-cell variation.

Flow cytometry represents an accessible entry point for single-cell analysis. While challenging in yeast due to cell wall barriers, optimized protocols using mild fixation and permeabilization can enable intracellular staining with SPBC1773.06c antibody. This approach allows quantification of SPBC1773.06c levels across thousands of individual cells and can be combined with DNA content staining to correlate expression with cell cycle position.

For higher-dimensional analysis, mass cytometry (CyTOF) permits simultaneous measurement of SPBC1773.06c alongside dozens of other proteins in individual cells when suitable metal-conjugated antibodies are developed. Though expensive, this approach can reveal complex regulatory relationships between SPBC1773.06c and other cellular factors.

Microscopy-based approaches offer spatial information alongside quantification. High-content imaging using fluorescently-labeled SPBC1773.06c antibody or expression of fluorescent protein fusions enables visualization of protein localization and abundance at the single-cell level. Automated image analysis can extract quantitative features from thousands of cells.

Microfluidic platforms allow tracking of SPBC1773.06c dynamics in individual live cells over time. Devices can trap individual yeast cells while allowing media exchange, enabling observation of SPBC1773.06c responses to environmental perturbations at single-cell resolution.

For transcriptional analysis, single-cell RNA sequencing can reveal the relationship between SPBC1773.06c mRNA expression and broader transcriptional programs. While technically challenging in yeast due to cell wall barriers, optimized protocols for S. pombe single-cell RNA-seq have been developed.

What quality control metrics should researchers implement when using SPBC1773.06c antibody in quantitative assays?

Implementing rigorous quality control metrics is essential for generating reliable quantitative data with SPBC1773.06c antibody. A comprehensive QC framework should address multiple aspects of the experimental pipeline.

First, antibody performance must be assessed through standard curve analysis using recombinant SPBC1773.06c protein at known concentrations. This calibration curve should demonstrate a linear relationship between protein concentration and signal intensity within the working range. The lower limit of detection (LLOD) and lower limit of quantification (LLOQ) should be determined and documented. Intra-assay precision should be evaluated by analyzing technical replicates of the same sample within a single experiment, with coefficient of variation (CV) values below 15% considered acceptable for most applications. Inter-assay precision requires analyzing the same samples across multiple independent experiments, with CV values below 20% generally considered acceptable.

Specificity controls are particularly important and should include samples from SPBC1773.06c knockout strains to confirm absence of non-specific signals. Additional controls should include pre-incubation of antibody with recombinant SPBC1773.06c to demonstrate signal blocking.

For experiments spanning multiple antibody lots, lot-to-lot variation should be assessed by analyzing reference samples with both the current and new lot. Deviations exceeding 20% warrant development of a correction factor or consideration of an alternative lot.

Sample stability should be evaluated by subjecting representative samples to anticipated storage conditions and processing steps, with acceptance criteria of <15% variation in measured values.

How can SPBC1773.06c antibody be applied in studying stress responses in fission yeast?

SPBC1773.06c antibody provides a valuable tool for investigating stress response mechanisms in S. pombe, offering insights into how this protein may function under various cellular stresses. While specific stress-related functions of SPBC1773.06c are not well-characterized in the provided search results, researchers can implement systematic approaches to elucidate its potential roles.

To study oxidative stress responses, researchers can expose S. pombe cultures to hydrogen peroxide or menadione at sublethal concentrations, then monitor SPBC1773.06c expression, localization, and modification patterns using the antibody in Western blot and immunofluorescence applications. Temporal analysis at multiple timepoints following stress induction (5 minutes to 24 hours) can reveal dynamic responses.

For heat shock experiments, shifting cultures from 30°C to 37-42°C allows examination of SPBC1773.06c behavior under temperature stress. Similarly, nutritional stress responses can be studied by transferring cells from rich to minimal media or implementing nitrogen/carbon source limitations while monitoring SPBC1773.06c.

Co-immunoprecipitation with SPBC1773.06c antibody followed by mass spectrometry analysis under different stress conditions can identify stress-specific interaction partners, potentially placing SPBC1773.06c within known stress response pathways. Chromatin immunoprecipitation (if SPBC1773.06c has DNA-binding properties) could reveal stress-dependent genomic associations.

These approaches should be complemented by genetic studies comparing wild-type and SPBC1773.06c deletion strains for growth, survival, and molecular responses under stress conditions. Integration of antibody-based protein analysis with genetic phenotyping and transcriptomic data would provide a comprehensive understanding of SPBC1773.06c's role in stress adaptation.

What strategies can optimize antibody-based detection of SPBC1773.06c in fixed versus live cell imaging applications?

Optimizing SPBC1773.06c visualization in microscopy applications requires different approaches for fixed and live cell imaging. For fixed cell applications using the SPBC1773.06c antibody, permeabilization optimization is critical. S. pombe cell walls require stronger permeabilization than mammalian cells, typically achieved through enzymatic digestion with zymolyase or lysing enzymes followed by detergent treatment (0.1-0.5% Triton X-100). Fixation methods significantly impact epitope accessibility - comparing formaldehyde (preserves structure but may mask epitopes) versus methanol (harsher but better epitope exposure) fixation is recommended. Signal amplification through tyramide signal amplification or fluorescent secondary antibody selection can enhance detection sensitivity. Z-stack acquisition with deconvolution significantly improves signal-to-noise ratio for low-abundance proteins.

For live cell imaging, antibody-independent approaches are necessary. CRISPR/Cas9-mediated endogenous tagging of SPBC1773.06c with fluorescent proteins (mNeonGreen or mScarlet for brightness) provides the most physiologically relevant approach. The tag position (N-terminal versus C-terminal) should be tested empirically to determine which preserves protein function. For dynamic studies, photoconvertible fluorescent proteins like mEos or Dendra2, or photoactivatable fluorescent proteins can track SPBC1773.06c movement within cells. Time-lapse imaging parameters should balance temporal resolution against photobleaching and phototoxicity.

Both approaches benefit from careful selection of microscopy methods based on experimental goals - confocal for optimal optical sectioning, spinning disk for rapid live-cell imaging, or super-resolution techniques for detailed localization studies.

How might advances in single-molecule detection technologies enhance research using SPBC1773.06c antibody?

Emerging single-molecule detection technologies offer transformative potential for SPBC1773.06c research, enabling analysis at unprecedented resolution and sensitivity. Techniques like single-molecule pull-down (SiMPull) combine antibody-based capture with single-molecule fluorescence detection, allowing researchers to isolate SPBC1773.06c complexes and visualize individual molecular interactions. This approach could reveal heterogeneity in complex composition that would be masked in bulk measurements.

Single-molecule Förster Resonance Energy Transfer (smFRET) could be applied to study conformational changes in SPBC1773.06c when purified protein is labeled with appropriate donor/acceptor fluorophores. This approach provides insights into protein dynamics under different conditions that are impossible to obtain from static structural methods.

For ultra-sensitive detection, digital ELISA platforms like Simoa technology can detect proteins at femtomolar concentrations - potentially enabling measurement of SPBC1773.06c in highly dilute samples or capturing expression in rare cell subtypes. These platforms work by isolating individual enzyme-labeled immunocomplexes in femtoliter-sized wells and detecting the fluorescent products generated.

Single-molecule tracking in live cells, using either antibody fragments conjugated to quantum dots or genetic fusion to photoactivatable fluorescent proteins, could reveal the mobility and binding kinetics of SPBC1773.06c in its native cellular environment. This approach enables calculation of diffusion coefficients and binding/unbinding rates that provide functional insights.